Biliary Tract Cancer: Molecular Biology of Precursor Lesions

被引:2
|
作者
Manzano-Nunez, Fatima [1 ]
Aguilar, Lara Prates Tiago [1 ]
Sempoux, Christine [2 ]
Lemaigre, Frederic P. [1 ]
机构
[1] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75-B1-7503, B-1200 Brussels, Belgium
[2] Univ Lausanne, Lausanne Univ Hosp CHUV, Inst Pathol, Lausanne, Switzerland
关键词
cholangiocarcinoma; gallbladder cancer; tumor progression; animal model; organoid; INTRADUCTAL PAPILLARY NEOPLASMS; GALLBLADDER CARCINOMA; PRENEOPLASTIC LESIONS; IMMUNOHISTOCHEMICAL ANALYSIS; INTRAEPITHELIAL NEOPLASIA; KRAS ACTIVATION; BETA-CATENIN; BILE-DUCTS; MUTATIONS; PROGRESSION;
D O I
10.1055/a-2207-9834
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Biliary tract cancer is a devastating malignancy of the bile ducts and gallbladder with a dismal prognosis. The study of precancerous lesions has received considerable attention and led to a histopathological classification which, in some respects, remains an evolving field. Consequently, increasing efforts have been devoted to characterizing the molecular pathogenesis of the precursor lesions, with the aim of better understanding the mechanisms of tumor progression, and with the ultimate goal of meeting the challenges of early diagnosis and treatment. This review delves into the molecular mechanisms that initiate and promote the development of precursor lesions of intraand extrahepatic cholangiocarcinoma and of gallbladder carcinoma. It addresses the genomic, epigenomic, and transcriptomic landscape of these precursors and provides an overview of animal and organoid models used to study them. In conclusion, this review summarizes the known molecular features of precancerous lesions in biliary tract cancer and highlights our fragmentary knowledge of the molecular pathogenesis of tumor initiation.
引用
收藏
页码:472 / 484
页数:13
相关论文
共 50 条
  • [21] Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
    Awosika, Joy A.
    Monge, Cecilia
    Greten, Tim F.
    HEPATIC ONCOLOGY, 2024, 11 (01)
  • [22] Biliary tract cancer: on the way to a personalized therapy
    Sinn, Marianne
    Wege, Henning
    Stein, Alexander
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (07) : 442 - 446
  • [23] How I treat biliary tract cancer
    Lamarca, A.
    Edeline, J.
    Goyal, L.
    ESMO OPEN, 2022, 7 (01)
  • [24] Molecular genetics and targeted therapeutics in biliary tract carcinoma
    Eric I Marks
    Nelson S Yee
    World Journal of Gastroenterology, 2016, (04) : 1335 - 1347
  • [25] Biliary tract cancer prognostic and predictive genomics
    Mondaca, Sebastian
    Nervi, Bruno
    Pinto, Mauricio
    Abou-Alfa, Ghassan K.
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (04)
  • [26] The Value of Molecular Biomarkers in Biliary Tract Cancer in the Era of Targeted Therapy
    Anand, Anil C.
    Puri, Pankaj
    Dhar, Brig A. K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2011, 1 (01) : 2 - 5
  • [27] Histological features of precancerous and early cancerous lesions of biliary tract carcinoma
    Aishima, Shinichi
    Kubo, Yuichiro
    Tanaka, Yuki
    Oda, Yoshinao
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (07) : 448 - 452
  • [28] Precursor lesions in familial and hereditary pancreatic cancer
    Pfluger, Michael J.
    Brosens, Lodewijk A. A.
    Hruban, Ralph H.
    FAMILIAL CANCER, 2024, 23 (03) : 267 - 278
  • [29] Immunotherapy of biliary tract cancer
    Chai, Yi
    TUMOR BIOLOGY, 2016, 37 (03) : 2817 - 2821
  • [30] Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm
    Patra, Krushna C.
    Bardeesy, Nabeel
    Mizukami, Yusuke
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2017, 8